Copies of the Matchstick for ME brochure
(click on the image above) are available from Invest in ME to be distributed to hospitals, doctors, universities, politicians and the media.
Please contact us.
Invest in ME Research
is an independent UK charity finding, funding and facilitating a strategy of biomedical research into Myalgic Encephalomyelitis (ME or ME/CFS),
as defined by WHO-ICD-10-G93.3.
and promoting better education about ME.
Invest in ME Research is run by volunteers - patients or parents of children with ME -
with no paid staff.
Overheads are kept to a minimum to enable all funds raised to go to promoting education of, and facilitating and funding biomedical research into, ME.
The charity believes that biomedical research into ME is crucial in order to make progress in treating this disease.
We also believe that education of healthcare staff, the media, government departments, patient groups and patients is
to be a priority.
The charity's objectives are to initiate, maintain and augment a strategy of high-quality biomedical research into ME, to
provide education about ME, and to raise awareness of the effects of the disease on patients and families.
We are a small charity but with supporters who have big hearts - and a determination
to get the best possible research to be carried out to find the cause of myalgic encephalomyelitis and develop treatments.
We have links nationwide and also internationally.
Invest in ME Research is a founder member of the European ME Alliance (EMEA), a collaboration of European national charities and organisations.
The charity was also responsible for initiating
the European ME Research Group (EMERG) concept,
a collaboration of European researchers from major institutes.
The charity also has initiated the European ME Clinicians Council (EMECC),
a network of European clinicians who will work together and share experiences of treating ME in order to establish better standards for patient care.
We do not receive, and have never received funding from government or government organisations.
We believe that we need a national strategy of
biomedical research into ME to produce treatments and cures for this illness.
We have always believed that the seriousness of the situation regarding ME makes it necessary for governments to
provide "ring-fenced" funding for biomedical research in to ME (as was provided for HIV/AIDS) in order
to address the need for development of diagnostic tests and remedial treatments.
However, the charity does not believe in merely asking for funding - the charity has pursued of policy of raising funds itself for biomedical research in order
to fund research at top UK institutes. More information is available here.
We believe that clinicians should standardise on usage of the most up-to-date criteria (currently we emphasise the Canadian Criteria)
for diagnosis so that there is an agreed basis (noting that evolutionary improvement would be welcomed).
The charity organises an annual research Colloquium and
conference regularly attracting
delegates from over 15 countries and
funds research at Quadram Institute Bioscience/University of East Anglia and University College London as well as influencing collaboration elsewhere, in
UK, Europe and beyond.
Our conferences and colloquiums were organised from the beginning in order to provide
a platform for research and a means of facilitating education about ME.
In order to bring the best education and research to bear on ME and to find and facilitate the best
strategy of research into this disease the charity welcomes support for our work.
Our aim is to fund and facilitate research in order to establish an understanding of
the aetiology, pathogenesis and epidemiology of ME. We hope this will lead to the development of a
universal diagnostic test(s) that can confirm the presence of ME and, subsequently, medical
treatments to cure or alleviate the effects of the illness
Our efforts are focused on setting up a UK/European Centre of Excellence for ME
which will provide proper examinations and diagnosis for ME patients and a
coordinated strategy of biomedical research into ME in order to find treatment(s) and